Mergers & AcquisitionsBy The Online Investor Staff, updated Thu., Mar. 4, 2:23 PM
|This Slide: #59 of 100|
Slide #59. Delic Holdings Inc. — Complex Biotech Discovery Ventures Ltd.
Delic Holdings Inc. (DELCF)
Complex Biotech Discovery Ventures Ltd.
Delic Holdings Inc. ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to announce it has executed a definitive share purchase agreement (the "Agreement") to acquire all of the issued and outstanding shares in the capital of Complex Biotech Discovery Ventures ("CBDV"), a licensed psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development (the "Transaction"). Founded by award-winning chemist, Dr. Markus Roggen, and UBC Professor, Glenn Sammis, CBDV supports the psychedelic industry with high precision chemical analytics and metabolomic identification. Following the Transaction, CBDV expects to change its name to "DELIC Labs".
Strong Buy (3.50 out of 4)